【レポートの概要（一部）】
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption
3.3.1.2. Advantages offered By Continuous Manufacturing Systems
3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems
3.3.2. Restraint
3.3.2.1. Poor Demand In Under Developed Countries
3.3.3. Opportunities
3.3.3.1. Growth Opportunities In Emerging Markets
3.3.4. Impact Analysis
Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Integrated Continuous Systems
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Semi-Continuous Systems
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Control & Software
4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Final Drug Product Manufacturing
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Api Manufacturing
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country
Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Pharmaceutical Companies
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Contract Manufacturing Organizations
6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country
6.4. Others
6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country
Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User
7.2.2.2. Canada
7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User
7.2.2.3. Mexico
7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User
7.2.3. North America Market Size And Forecast, By Product
7.2.4. North America Market Size And Forecast, By Application
7.2.5. North America Market Size And Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.2. France
7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.3. Uk
7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.4. Italy
7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.5. Rest of Europe
7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User
7.3.3. Europe Market Size And Forecast, By Product
7.3.4. Europe Market Size And Forecast, By Application
7.3.5. Europe Market Size And Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.2. China
7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.3. India
7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User
7.4.3. Asia-Pacific Market Size And Forecast, By Product
7.4.4. Asia-Pacific Market Size And Forecast, By Application
7.4.5. Asia-Pacific Market Size And Forecast, By End User
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.2. South Africa
7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.4. Rest of Lamea
7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User
7.5.3. Lamea Market Size And Forecast, By Product
7.5.4. Lamea Market Size And Forecast, By Application
7.5.5. Lamea Market Size And Forecast, By End User
Chapter 8: Company Profiles
8.1. Coperion Gmbh
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Key Strategic Moves And Developments
8.2. Gea Group Ag
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.3. Gebrüder Lödige Maschinenbau Gmbh
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.4. Glatt Gmbh
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.5. Hosokawa Micron Corporation
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Product Portfolio
8.5.4. Business Performance
8.6. Korsch Ag
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.7. L.B. Bohle Maschinen + Verfahren Gmbh
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.8. Munson Machinery Company, Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.9. Robert Bosch Packaging Technology Gmbh
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Thermo Fisher Scientific, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
【レポート販売概要】
■ タイトル：医薬品連続製造の世界市場：製品別（統合連続システム、半連続システム、制御＆ソフトウェア）、用途別（最終医薬品製造、API製造）、エンドユーザー別（製薬会社、受託製造組織、その他）■ 英文：Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年12月31日
■ 調査会社：Allied Market Research
■ 商品コード：AMR20FE046
■ 調査対象地域：グローバル
- 歯科用3Dプリンティング機器の世界市場2019-2023About this market Strategic collaborations and M&A to drive market growth. The global dental 3D printing devices market is observing a trend of strategic collaborations and M&A. Vendors are increasingly collaborating with other companies and research institutions to develop new technologies, enhance their product offerings, and expand their distribution networks. Technavio’s analysts have predicte …
- LTE上のビデオサービスROI分析：The ROI of Video in an LTE WorldWith the introduction of the 4G LTE networks and the associated high speed data rates, videos become much a much more pleasant experience. Accordingly, the industry is counting on video being the initial big non-voice application. While carriers are settling VoLTE operations, they will simultaneously offer various video over LTE services and associated applications. The introduction of IMS with LT …
- インダクタの世界市場：固定インダクタ、可変インダクタ、結合インダクタ、多層インダクタ、パワーインダクタ、面実装インダクタInductors are one of the four fundamental types of passive electronic components, the other three being the resistor, the capacitor, and the memristor. Inductors are formed with the help of a wire tightly wrapped around a solid central core, to concentrate their magnetic flux. The inductor market has been segmented with respect to types including fixed, variable, couple, surface mount, multilayer, …
- クラウド型BPOの世界市場2015-2019About cloud-based BPO Over the years, enterprises worldwide have become increasingly dependent on technology and various software products to run their business and drive revenue growth. This trend is expected to intensify, and therefore the role of outsourcing the business processes to third party vendors has become vital and it directly contributes to the organization’s agenda. Cloud computing h …
- 脅威検出装置の世界市場予測（～2022年）：爆発物検知、放射線・核検知、化学・生物学的検知、麻薬検知、侵入検知The threat detection systems market was valued at USD 48.38 Billion in 2015 and is expected to reach USD 119.17 Billion by 2022, at a CAGR of 13.11% during the forecast period. The growth of this market is driven by the increase in the terrorist activities and rising territorial conflicts and geopolitical instabilities. Government regulations also play an important role in the increasing demand fo …
- 神経損傷(Nerve Injury)の治療薬パイプライン動向（2015年上半期版）Nerve Injury - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Nerve Injury - Pipeline Review, H1 2015’, provides an overview of the Nerve Injury’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nerve Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ro …
- 心室細動：グローバル臨床試験レビューH2, 2013Ventricular Fibrillation Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ventricular Fibrillation Global Clinical Trials Review, H2, 2013" provides data on the Ventricular Fibrillation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Fibrillation. It includes an overview of the trial num …
- 世界の受動部品（レジスタ、キャパシタ、インダクタ）市場（2014-2018）About Passive Components A passive component is a module that does not require any source of energy to perform its function in any given application. Capacitors, inductors, and resistors are the main types of passive component. They are used to control the intensity of the current or voltage in a circuit. Passive components are used in industry to improve the energy efficiency, life, and performan …
- グローバルにおける農業・林業用トラクター市場（～2019）The industry report Global Agricultural and Forestry Tractor Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for agricultural and forestry tractors in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for ind …
- 生体認証技術の世界市場分析：用途別（顔、掌形、音声、サイン、虹彩、AFIS、非AFIS）、エンドユーザー別（政府、銀行及び金融、消費者家電、ヘルスケア、防衛･保安）、地域別、セグメント予測、2014-2025The global biometrics technology market is expected to reach USD 59.31 billion by 2025, according to a new study by Grand View Research, Inc. The increasing demand for biometrics technology across various applications is expected to favor the market growth over the next nine years. Biometrics technology is used by several verticals in private, public, and commercial sectors to overcome security th …
- 痙攣（Convulsions）：グローバル臨床試験レビュー（2014年上半期）Convulsions Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Convulsions Global Clinical Trials Review, H1, 2014" provides data on the Convulsions clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Convulsions. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 企業間エネルギートレーディング動向：Business to Business Energy TradingThe energy community is slowly emerging from two decades of obsession with speculation and trading. The era of the energy traders began in the early 1980s, with the deregulation of oil markets by the Reagan and Thatcher administrations, gathered force as Enron and its fellow travelers extended the trading culture to the natural gas and later electricity businesses, and came to an abrupt end in 200 …
- パーソナルケア用包装の世界市場The global personal care packaging market is expected to reach $28.1bn in 2018 and develop dynamically over the forecast period, driven by emerging economies. Visiongain scrutinises the 17 leading national markets revealing where the business opportunities are: Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Rest of Asia-Pacific, Rest of Europe, Rest of LAMEA, Russia, South Af …
- 温度センサーの世界市場展望2017-20276According to Stratistics MRC, the Global Temperature Sensors market is accounted for $5.29 billion in 2017 and is expected to reach $9.56 billion by 2026 growing at a CAGR of 6.8% during the forecast period. Some of the key factors such as the recent technical advancement in petrochemical manufacturing, growing approval of home and building automation systems, rising massive demand of medical sens …
- Market Opportunity: Next Generation Virtual Network OperatorsVirtual Network Operations (VNO) represents an enormous opportunity for telecommunications on a medium to longer term basis. With margins continuing to erode for core bearer services, network operators of all type must offer value-added services (VAS) for profitability. The VAS applications will tend to be those offered by various third parties in a VNO environment facilitated by Service Delivery …
